Progress towards the development of Klebsiella vaccines
Introduction: Klebsiella pneumoniae (KP) are a leading cause of healthcare-associated infections. The dramatic increase in microbial resistance to third-generation cephalosporin and carbapenem ‘front line’ antimicrobial agents and the paucity of new antimicrobials have left clinicians with few thera...
Main Authors: | Myeongjin Choi, Sharon M Tennant, Raphael Simon, Alan S Cross |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-07-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2019.1635460 |
Similar Items
-
Development and evaluation of a novel vaccine against prevalent invasive multi-drug resistant strains of Streptococcus pneumoniae
by: Rehab H. Bahy, et al.
Published: (2016-11-01) -
Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products
by: M. V. Abramtseva, et al.
Published: (2021-07-01) -
Effects of gallic acid on capsular polysaccharide biosynthesis in Klebsiella pneumoniae
by: Tien-Huang Lin, et al.
Published: (2022-12-01) -
Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them
by: Paeton L. Wantuch, et al.
Published: (2018-09-01) -
Unusual Hypermucoviscous Clinical Isolate of Klebsiella pneumoniae with No Known Determinants of Hypermucoviscosity
by: Tamal Dey, et al.
Published: (2022-06-01)